{"name": "Invitrogen",
 "permalink": "invitrogen",
 "crunchbase_url": "http://www.crunchbase.com/company/invitrogen",
 "homepage_url": "http://www.invitrogen.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1987,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Mon Jul 13 16:32:05 UTC 2009",
 "updated_at": "Thu Sep 10 23:38:16 UTC 2009",
 "overview": "\u003Cp\u003EInvitrogen Corporation (NASDAQ: IVGN - News) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction.\u003C/p\u003E\n\n\u003Cp\u003EInvitrogen\u0026#8217;s own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bioinformatics and cell biology \u0026#8211; placing Invitrogen\u0026#8217;s products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. The company employs approximately 4,700 scientists and other professionals and had revenues of more than $1.15 billion in 2006.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       28],
      "assets/images/resized/0005/9423/59423v1-max-150x150.png"],
     [[168,
       32],
      "assets/images/resized/0005/9423/59423v1-max-250x250.png"],
     [[168,
       32],
      "assets/images/resized/0005/9423/59423v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": true,
    "title": "Chief Science Officer",
    "person":
     {"first_name": "Joseph",
      "last_name": "M. Beechem",
      "permalink": "joseph-m-beechem",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0027/2674/272674v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0027/2674/272674v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0027/2674/272674v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Territory Manager",
    "person":
     {"first_name": "Dale",
      "last_name": "R. Levitzke",
      "permalink": "dale-r-levitzke",
      "image":
       {"available_sizes":
         [[[120,
            120],
           "assets/images/resized/0027/2643/272643v1-max-150x150.jpg"],
          [[120,
            120],
           "assets/images/resized/0027/2643/272643v1-max-250x250.jpg"],
          [[120,
            120],
           "assets/images/resized/0027/2643/272643v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [{"funding_round":
     {"round_code": "b",
      "source_url": "http://www.qthera.com/index.php/news-events/q-therapeutics-announces-series-b-investment.html",
      "source_description": "Q THERAPEUTICS ANNOUNCES SERIES B INVESTMENT",
      "raised_amount": 8000000.0,
      "raised_currency_code": "USD",
      "funded_year": 2008,
      "funded_month": 2,
      "funded_day": 15,
      "company":
       {"name": "Q Therapeutics",
        "permalink": "q-therapeutics",
        "image":
         {"available_sizes":
           [[[114,
              108],
             "assets/images/resized/0007/0322/70322v1-max-150x150.jpg"],
            [[114,
              108],
             "assets/images/resized/0007/0322/70322v1-max-250x250.jpg"],
            [[114,
              108],
             "assets/images/resized/0007/0322/70322v1-max-450x450.jpg"]],
          "attribution": null}}}}],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 57000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.fiercebiotech.com/press-releases/invitrogen-announces-acquisition-cellzdirect",
    "source_description": "Invitrogen Announces Acquisition of CellzDirec",
    "acquired_year": 2008,
    "acquired_month": 1,
    "acquired_day": 10,
    "company":
     {"name": "CellzDirect",
      "permalink": "cellzdirect",
      "image":
       {"available_sizes":
         [[[150,
            41],
           "assets/images/resized/0005/8942/58942v1-max-150x150.jpg"],
          [[186,
            51],
           "assets/images/resized/0005/8942/58942v1-max-250x250.jpg"],
          [[186,
            51],
           "assets/images/resized/0005/8942/58942v1-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [{"description": "",
    "address1": "",
    "address2": "",
    "zip_code": "92008",
    "city": "Carlsbad",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}